New major risk - Share price stability Mar 19
New major risk - Financial position Mar 02
Third quarter 2026 earnings released: CA$0.018 loss per share (vs CA$0.087 profit in 3Q 2025) Mar 02
Less than half of directors are independent Feb 22
New major risk - Financial position Nov 12
Datametrex AI Limited (TSXV:DM) signed a non-binding of a Letter of Intent to acquire Yuzu Payment Processing Solution from Firstpayment Inc. for Sep 16
First quarter 2026 earnings released: CA$0.03 loss per share (vs CA$0.084 loss in 1Q 2025) Aug 31
New major risk - Shareholder dilution Aug 24
Full year 2025 earnings released: CA$0.048 loss per share (vs CA$1.42 loss in FY 2024) Aug 01
New major risk - Share price stability Jul 02
Datametrex AI Limited announced that it expects to receive CAD 3 million in funding Jun 09
Datametrex AI Limited (TSXV:DM) completed the acquisition of Arbutus Health and Wellness Inc. Jun 06
Third quarter 2025 earnings released: EPS: CA$0.08 (vs CA$0.51 loss in 3Q 2024) Mar 04
New major risk - Shareholder dilution Jan 16
Second quarter 2025 earnings released: CA$0.001 loss per share (vs CA$0.009 loss in 2Q 2024) Dec 01
Datametrex AI Limited, Annual General Meeting, Nov 13, 2024 Sep 24
Datametrex AI Limited Implements AI Technology at Imagine Health Centres To Streamline Patient Care and Enhance Healthcare Accessibility Sep 10
Datametrex AI Limited Announces Official Launch of Cereal Crunch on Google Play Store Sep 05
First quarter 2025 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in 1Q 2024) Sep 01
New major risk - Shareholder dilution Aug 23
Datametrex AI Limited announced that it has received CAD 1.521909 million in funding Aug 21
Full year 2024 earnings released: CA$0.047 loss per share (vs CA$0.05 loss in FY 2023) Aug 01
Datametrex AI Limited announced that it expects to receive CAD 1.5 million in funding Jun 14
New major risk - Revenue and earnings growth Mar 03
Full year 2023 earnings released: CA$0.034 loss per share (vs CA$0.045 loss in FY 2022) Mar 03
New minor risk - Shareholder dilution Feb 28
Datametrex AI Limited announced that it has received CAD 1 million in funding Feb 27
Datametrex AI Limited announced that it expects to receive CAD 1 million in funding Feb 02
Graph Blockchain Inc. (CNSX:GBLC) completed the acquisition of Datametrex Electric Vehicle Solutions from Datametrex AI Limited (TSXV:DM). Dec 08
Third quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.002 profit in 3Q 2022) Dec 01
New major risk - Market cap size Nov 16
Graph Blockchain Inc. (CNSX:GBLC) entered into an agreement to acquire Datametrex Electric Vehicle Solutions from Datametrex AI Limited (TSXV:DM) for approximately CAD 3.2 million. Nov 15
New major risk - Share price stability Nov 15
Insufficient new directors Nov 01
CEO & Director recently sold CA$98k worth of stock Oct 09
CEO & Director exercised options to buy CA$65k worth of stock. Oct 07
Datametrex AI Limited, Annual General Meeting, Dec 14, 2023 Oct 05
Datametrex AI Limited Appoints Young Jun Kim as New Head of Defense Business Development for the Company's Business Division in South Korea Sep 28
Nexalogy Environics Inc. Launches AnalyticsGPT Sep 20
Second quarter 2023 earnings released: CA$0.008 loss per share (vs CA$0.002 loss in 2Q 2022) Sep 01
Datametrex Electric Vehicle Solutions Inc. Expands Operations to Toronto Jul 26
First quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.007 profit in 1Q 2022) Jun 02
Datametrex AI Limited Announces the Appointment of Charles Park as Chief Operating Officer May 05
Full year 2022 earnings released: CA$0.045 loss per share (vs CA$0.028 profit in FY 2021) May 03
Chief Medical Officer recently sold CA$57k worth of stock Mar 12
Datametrex AI Limited (TSXV:DM) acquired Imagine Health Centers for $2.6 million. Dec 01
Third quarter 2022 earnings released: EPS: CA$0.002 (vs CA$0 in 3Q 2021) Nov 22
High number of new and inexperienced directors Nov 16
Datametrex AI Limited Appoints Mr. Charles Park as the President of Nexalogy Nov 03
CEO & Director recently bought CA$99k worth of stock Oct 22
Datametrex AI Limited Launches Smart Factory Platform Sep 17
Second quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.003 profit in 2Q 2021) Aug 26
Datametrex Ai Limited Announces Company's Wholly Owned Telehealth Subsidiary, Medi-Call Inc., Introduces Mental Health Services Jul 27
Datametrex AI Limited Announces Telehealth Medi-Call App Is Now Available Jun 29
CEO & Director recently bought CA$99k worth of stock Jun 15
Less than half of directors are independent May 28
Datametrex AI Limited, Annual General Meeting, Jul 29, 2022 May 21
Datametrex AI Limited Announces Promotion Of Maxime Martineau as New Chief Technology Officer May 10
Executive Chairman recently bought CA$145k worth of stock May 06
Full year 2021 earnings: EPS and revenues miss analyst expectations May 03
Datametrex AI Limited to Report Fiscal Year 2021 Results on May 02, 2022 May 02
High number of new and inexperienced directors Apr 27
Datametrex AI Limited Launches Tele-Medicine Services Via Medi-Call App Apr 20
Datametrex Launches Beta Testing of Medi- Call Telehealth App Mar 03
Executive Chairman recently bought CA$121k worth of stock Jan 13
Third quarter 2021 earnings: Revenues miss analyst expectations Dec 01
Second quarter 2021 earnings released: EPS CA$0.003 (vs CA$0.003 loss in 2Q 2020) Aug 18
Datametrex AI Limited (TSXV:DM) completed the acquisition of Medi-Call Inc. Jun 22
First quarter 2021 earnings released: EPS CA$0.034 (vs CA$0.003 loss in 1Q 2020) Jun 04
Full year 2020 earnings released: CA$0.02 loss per share (vs CA$0.012 loss in FY 2019) May 03
Independent Director has left the company Mar 25
Executive Chairman recently sold CA$1.6m worth of stock Mar 24
Datametrex AI Limited (TSXV:DM) entered into a Letter of Intent to acquire Perspectum Drone Inspection Services Ltd. Mar 12
Executive Chairman exercised options to buy CA$1.7m worth of stock. Mar 11
New 90-day high: CA$0.22 Feb 18
Jibran Sharif to Become the Chief Medical Officer of Datametrex AI Limited Feb 13
Executive Chairman recently sold CA$434k worth of stock Feb 13
CEO & Director exercised options to buy CA$413k worth of stock. Feb 13
Datametrex AI Limited (TSXV:DM) completed the acquisition of Concierge Medical Consultant Inc. Feb 12
Datametrex AI Limited Secures Exclusive Rights to Sell and Distribute Covid-19 Saliva Kit Manufactured by WIZCHEM CO., LTD Feb 04
Independent Director exercised options and sold CA$67k worth of stock Jan 25
Datametrex AI Limited Expands LOTTE Agreements Jan 22
Executive Chairman recently sold CA$1.5m worth of stock Jan 21
CEO & Director exercised options to buy CA$287k worth of stock. Jan 17
Datametrex Provides Covid-19 Testing for Air Canada Front-Line and Inflight Employees Jan 12